BFEC
FBT icon

Benjamin F. Edwards & Company’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Benjamin F. Edwards & Company’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$2.91M Sell
18,899
-6
-0% -$900 0.05% 312
2024
Q1 		$2.91M Buy
18,905
+508
+3% +$77.5K 0.05% 295
2023
Q4 		$2.91M Sell
18,397
-1,638
-8% -$235K 0.06% 275
2023
Q3 		$2.93M Buy
20,035
+2,599
+15% +$396K 0.11% 180
2023
Q2 		$2.67M Buy
17,436
+207
+1% +$32.3K 0.1% 197
2023
Q1 		$2.67M Sell
17,229
-1,638
-9% -$257K 0.11% 188
2022
Q4 		$2.91M Buy
18,867
+455
+2% +$67.1K 0.13% 162
2022
Q3 		$2.43M Sell
18,412
-2,823
-13% -$396K 0.12% 174
2022
Q2 		$2.88M Buy
21,235
+293
+1% +$40.4K 0.14% 158
2022
Q1 		$3.12M Sell
20,942
-3,946
-16% -$584K 0.14% 162
2021
Q4 		$4.03M Buy
24,888
+1,160
+5% +$188K 0.18% 123
2021
Q3 		$3.94M Sell
23,728
-658
-3% -$112K 0.2% 116
2021
Q2 		$4.21M Sell
24,386
-644
-3% -$106K 0.21% 110
2021
Q1 		$4.02M Buy
25,030
+1,278
+5% +$219K 0.22% 112
2020
Q4 		$3.99M Buy
23,752
+1,528
+7% +$248K 0.24% 107
2020
Q3 		$3.5M Buy
22,224
+193
+0.9% +$31.6K 0.23% 107
2020
Q2 		$3.7M Buy
22,031
+5,274
+31% +$828K 0.27% 88
2020
Q1 		$2.2M Buy
16,757
+9,541
+132% +$1.36M 0.19% 134
2019
Q4 		$1.07M Sell
7,216
-9,268
-56% -$1.27M 0.08% 266
2019
Q3 		$2.04M Sell
16,484
-36,969
-69% -$4.92M 0.16% 166
2019
Q2 		$7.53M Buy
53,453
+1,252
+2% +$173K 0.63% 29
2019
Q1 		$7.88M Sell
52,201
-4,022
-7% -$579K 0.71% 27
2018
Q4 		$6.98M Buy
56,223
+28,932
+106% +$3.96M 0.72% 29
2018
Q3 		$4.33M Buy
27,291
+23,375
+597% +$3.54M 0.41% 57
2018
Q2 		$548K Buy
3,916
+96
+3% +$13.2K 0.05% 309
2018
Q1 		$508K Buy
3,820
+179
+5% +$24.4K 0.05% 325
2017
Q4 		$454K Buy
3,641
+1,534
+73% +$190K 0.05% 329
2017
Q3 		$261K Buy
2,107
+1,592
+309% +$188K 0.03% 396
2017
Q2 		$59K Buy
515
+180
+54% +$19.4K 0.01% 681
2017
Q1 		$35K Hold
335
– – 0.01% 741
2016
Q4 		$30K Hold
335
– – ﹤0.01% 719
2016
Q3 		$33K Hold
335
– – 0.01% 621
2016
Q2 		$30K Sell
335
-20
-6% -$1.84K 0.01% 605
2016
Q1 		$31K Sell
355
-43,514
-99% -$3.83M 0.01% 596
2015
Q4 		$4.96M Buy
43,869
+1,125
+3% +$121K 1.07% 19
2015
Q3 		$4.33M Sell
42,744
-12,411
-23% -$1.48M 0.95% 25
2015
Q2 		$6.84M Buy
55,155
+4,060
+8% +$490K 1.36% 11
2015
Q1 		$6.04M Buy
51,095
+2,373
+5% +$268K 1.27% 11
2014
Q4 		$4.97M Buy
48,722
+11,823
+32% +$1.15M 1.15% 16
2014
Q3 		$3.39M Buy
36,899
+13,685
+59% +$1.19M 0.85% 23
2014
Q2 		$1.91M Buy
23,214
+2,329
+11% +$178K 0.49% 44
2014
Q1 		$1.6M Buy
20,885
+1,102
+6% +$86K 0.44% 48
2013
Q4 		$1.37M Buy
19,783
+2,859
+17% +$188K 0.46% 51
2013
Q3 		$1.1M Buy
16,924
+1,417
+9% +$89.6K 0.41% 59
2013
Q2 		$902K Buy
+15,507
New +$886K 0.36% 68

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Benjamin F. Edwards & Company's FBT Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.03% in Q2 2024, selling an estimated $900 and leaving 18,899 shares worth $2.91M. The position accounts for 0.05% of the portfolio, ranked #312.

Benjamin F. Edwards & Company first reported a position in FBT in Q2 2013 and has held it in 45 quarters since. The position peaked at $7.88M in Q1 2019. 251 funds tracked by Wall St. Rank hold FBT as of Q2 2024.

  • Benjamin F. Edwards & Company held 18,899 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.91M as of Q2 2024.
  • Benjamin F. Edwards & Company sold 6 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2024, an estimated $900.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.05% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #312 holding.
  • Benjamin F. Edwards & Company first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 45 quarters since.
  • Benjamin F. Edwards & Company's First Trust NYSE Arca Biotechnology Index Fund position peaked at $7.88M in Q1 2019.
  • 251 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.